{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:17:32Z","timestamp":1787671052135,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":470,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T.0069.15"],"award-info":[{"award-number":["T.0069.15"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T.0016.20"],"award-info":[{"award-number":["T.0016.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["FAF\u2010C\/2016\/889"],"award-info":[{"award-number":["FAF\u2010C\/2016\/889"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1111\/ajt.16505","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T09:25:35Z","timestamp":1611912335000},"page":"2662-2674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7018-1770","authenticated-orcid":false,"given":"Gr\u00e9gory","family":"Ehx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ritacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Delens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Drion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Beguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1111\/ajt.16505_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00281-004-0165-3","article-title":"Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review","volume":"26","author":"Baron","year":"2004","journal-title":"Springer Semin Immunopathol."},{"issue":"2","key":"10.1111\/ajt.16505_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bjh.14295","article-title":"Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation","volume":"175","author":"Zeiser","year":"2016","journal-title":"Br J Haematol."},{"issue":"1 Suppl","key":"10.1111\/ajt.16505_bib3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.bbmt.2009.10.016","article-title":"Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?","volume":"16","author":"Storb","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"10.1111\/ajt.16505_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2141.2000.01809.x","article-title":"The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation","volume":"108","author":"Bacigalupo","year":"2000","journal-title":"Br J Haematol."},{"issue":"6","key":"10.1111\/ajt.16505_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3324\/haematol.2009.013920","article-title":"Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia","volume":"95","author":"Craddock","year":"2010","journal-title":"Haematologica."},{"issue":"5","key":"10.1111\/ajt.16505_bib6","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4049\/jimmunol.162.5.2775","article-title":"Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation","volume":"162","author":"Powell","year":"1999","journal-title":"J Immunol."},{"issue":"4","key":"10.1111\/ajt.16505_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ajt.13151","article-title":"Evolving perspectives of mTOR complexes in immunity and transplantation","volume":"15","author":"Fantus","year":"2015","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.16505_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol."},{"issue":"5","key":"10.1111\/ajt.16505_bib9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8(+) T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1111\/ajt.16505_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood."},{"issue":"9","key":"10.1111\/ajt.16505_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705628","article-title":"Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells","volume":"39","author":"Coenen","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1111\/ajt.16505_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/leu.2014.180","article-title":"Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors","volume":"29","author":"Peccatori","year":"2015","journal-title":"Leukemia."},{"issue":"8","key":"10.1111\/ajt.16505_bib13","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1600-6143.2012.04065.x","article-title":"Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo","volume":"12","author":"Hester","year":"2012","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.16505_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood."},{"issue":"1","key":"10.1111\/ajt.16505_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11899-013-0187-9","article-title":"Thinking out of the box\u2013new approaches to controlling GVHD","volume":"9","author":"Baron","year":"2014","journal-title":"Curr Hematol Malig Rep."},{"issue":"5","key":"10.1111\/ajt.16505_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bcp.13022","article-title":"New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease","volume":"82","author":"Lutz","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"10.1111\/ajt.16505_bib17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3389\/fimmu.2018.01943","article-title":"Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2\/HHD mice","volume":"9","author":"Ehx","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1111\/ajt.16505_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1314425","article-title":"Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects","volume":"6","author":"Ehx","year":"2017","journal-title":"Oncoimmunology."},{"issue":"2","key":"10.1111\/ajt.16505_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cei.12051","article-title":"Human T cells depend on functional calcineurin, tumour necrosis factor-alpha and CD80\/CD86 for expansion and activation in mice","volume":"172","author":"Sondergaard","year":"2013","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"10.1111\/ajt.16505_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","article-title":"Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex","volume":"157","author":"King","year":"2009","journal-title":"Clin Exp Immunol."},{"issue":"12","key":"10.1111\/ajt.16505_bib21","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood."},{"issue":"6","key":"10.1111\/ajt.16505_bib22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","article-title":"Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease","volume":"11","author":"Hippen","year":"2011","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.16505_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"10.1111\/ajt.16505_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaci.2015.12.1314","article-title":"IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis","volume":"138","author":"Humblet-Baron","year":"2016","journal-title":"J Allergy Clin Immunol."},{"issue":"7","key":"10.1111\/ajt.16505_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol."},{"issue":"9","key":"10.1111\/ajt.16505_bib26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.exphem.2006.05.001","article-title":"Molecular and functional evidence for activity of murine IL-7 on human lymphocytes","volume":"34","author":"Barata","year":"2006","journal-title":"Exp Hematol."},{"issue":"5","key":"10.1111\/ajt.16505_bib27","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.4049\/jimmunol.166.5.3201","article-title":"Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes","volume":"166","author":"Slavik","year":"2001","journal-title":"J Immunol."},{"issue":"3","key":"10.1111\/ajt.16505_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"10.1111\/ajt.16505_bib29","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol."},{"issue":"10","key":"10.1111\/ajt.16505_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3322","article-title":"Paths to stemness: building the ultimate antitumour T cell","volume":"12","author":"Gattinoni","year":"2012","journal-title":"Nat Rev Cancer."},{"issue":"10","key":"10.1111\/ajt.16505_bib31","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2003-09-3286","article-title":"Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells","volume":"103","author":"Yamashita","year":"2004","journal-title":"Blood."},{"issue":"7","key":"10.1111\/ajt.16505_bib32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbmt.2015.04.010","article-title":"Peripheral blood CD38 bright CD8+ effector memory T cells predict acute graft-versus-host disease","volume":"21","author":"Khandelwal","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"10.1111\/ajt.16505_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbmt.2014.12.009","article-title":"High number of memory t cells is associated with higher risk of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"21","author":"Loschi","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"10.1111\/ajt.16505_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood."},{"issue":"4","key":"10.1111\/ajt.16505_bib35","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood."},{"issue":"16","key":"10.1111\/ajt.16505_bib36","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0959-8049(01)00256-8","article-title":"Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect","volume":"37","author":"Calastretti","year":"2001","journal-title":"Eur J Cancer."},{"issue":"4","key":"10.1111\/ajt.16505_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/auto.6.4.11811","article-title":"Rapamycin generates anti-apoptotic human Th1\/Tc1 cells via autophagy for induction of xenogeneic GVHD","volume":"6","author":"Amarnath","year":"2010","journal-title":"Autophagy."},{"issue":"1","key":"10.1111\/ajt.16505_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/imr.12127","article-title":"Rapamycin-resistant effector T-cell therapy","volume":"257","author":"Fowler","year":"2014","journal-title":"Immunol Rev."},{"issue":"2","key":"10.1111\/ajt.16505_bib39","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1074\/jbc.M209733200","article-title":"Rapamycin-resistant proliferation of CD8+ T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity","volume":"279","author":"Slavik","year":"2004","journal-title":"J Biol Chem."},{"issue":"12","key":"10.1111\/ajt.16505_bib40","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.4049\/jimmunol.158.12.5642","article-title":"The regulation of p27Kip1 expression following the polyclonal activation of murine G0 T cells","volume":"158","author":"Kwon","year":"1997","journal-title":"J Immunol."},{"issue":"2","key":"10.1111\/ajt.16505_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.V91.2.561","article-title":"The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines","volume":"91","author":"Kawamata","year":"1998","journal-title":"Blood."},{"issue":"8","key":"10.1111\/ajt.16505_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/intimm\/dxh289","article-title":"IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice","volume":"17","author":"Gesbert","year":"2005","journal-title":"Int Immunol."},{"issue":"3","key":"10.1111\/ajt.16505_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.20051520","article-title":"IL-7 promotes T cell proliferation through destabilization of p27Kip1","volume":"203","author":"Li","year":"2006","journal-title":"J Exp Med."},{"issue":"9","key":"10.1111\/ajt.16505_bib44","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.4049\/jimmunol.175.9.5732","article-title":"Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism","volume":"175","author":"Foley","year":"2005","journal-title":"J Immunol."},{"issue":"11","key":"10.1111\/ajt.16505_bib45","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.160.11.5355","article-title":"Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines","volume":"160","author":"Blazar","year":"1998","journal-title":"J Immunol."},{"issue":"1","key":"10.1111\/ajt.16505_bib46","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun."},{"issue":"1","key":"10.1111\/ajt.16505_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J Hematol Oncol."},{"issue":"11","key":"10.1111\/ajt.16505_bib48","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.1600-6143.2008.02391.x","article-title":"mTOR, cancer and transplantation","volume":"8","author":"Geissler","year":"2008","journal-title":"Am J Transplant."},{"issue":"41","key":"10.1111\/ajt.16505_bib49","doi-asserted-by":"crossref","first-page":"43255","DOI":"10.18632\/oncotarget.6486","article-title":"Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets","volume":"6","author":"Ehx","year":"2015","journal-title":"Oncotarget."},{"issue":"12","key":"10.1111\/ajt.16505_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167215","article-title":"Time-Dependent Regulation of IL-2R alpha-chain (CD25) expression by TCR signal strength and IL-2-induced STAT5 signaling in activated human blood T lymphocytes","volume":"11","author":"Shatrova","year":"2016","journal-title":"PLoS One."},{"issue":"6","key":"10.1111\/ajt.16505_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005994","article-title":"Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin","volume":"4","author":"Strauss","year":"2009","journal-title":"PLoS One."},{"issue":"4","key":"10.1111\/ajt.16505_bib52","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI66204","article-title":"Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells","volume":"123","author":"Wang","year":"2013","journal-title":"J Clin Invest."},{"issue":"8","key":"10.1111\/ajt.16505_bib53","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/S2352-3026(19)30088-2","article-title":"Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial","volume":"6","author":"Sandmaier","year":"2019","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1111\/ajt.16505_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-016-0281-2","article-title":"Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease","volume":"9","author":"Fransolet","year":"2016","journal-title":"J Hematol Oncol."},{"issue":"11","key":"10.1111\/ajt.16505_bib55","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/bloodadvances.2020001688","article-title":"Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease","volume":"4","author":"Boucault","year":"2020","journal-title":"Blood Adv."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16505","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352208666X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352208666X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:33:30Z","timestamp":1761629610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352208666X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S160061352208666X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16505","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}